Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Peroxisome proliferator-activated receptor alpha (PPARA) has been suggested as a therapeutic target for chronic lymphocytic leukemia (CLL). However, the underlying molecular mechanism remains largely unclear. In this study, we analyzed DNA next-generation sequencing (NGS) data and clinical informati...
Saved in:
| Main Authors: | Xixi Xiang, Fu Li, Sha Zhou, Yunjing Zeng, Xiaojuan Deng, Hongyang Zhang, Jiali Li, Hongyun Liu, Jun Rao, Lei Gao, Cheng Zhang, Qin Wen, Li Gao, Xi Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2023/8456833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic Variability of RXRB, PPARA, and PPARG in Wegener's Granulomatosis
by: Stefan Wieczorek, et al.
Published: (2009-01-01) -
Association between single nucleotide polymorphisms in EPAS1 and PPARA genes and high altitude polycythemia in Chinese Tibetan population
by: Ziyi Chen, et al.
Published: (2025-03-01) -
Immunotherapy in chronic lymphocytic leukemia: advances and challenges
by: Pan Gao, et al.
Published: (2025-04-01) -
PPARɑ variant V227A reduces plasma triglycerides through enhanced lipoprotein lipolysis
by: Lauren F. Uchiyama, et al.
Published: (2025-05-01) -
Disruption of hindgut microbiome homeostasis promotes postpartum energy metabolism disorders in dairy ruminants by inhibiting acetate-mediated hepatic AMPK-PPARA axis
by: Shuo Wang, et al.
Published: (2025-07-01)